U.S. flag

An official website of the United States government

NM_014363.6(SACS):c.4466A>G (p.Asn1489Ser) AND not provided

Germline classification:
Benign/Likely benign (5 submissions)
Last evaluated:
May 1, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001358184.10

Allele description [Variation Report for NM_014363.6(SACS):c.4466A>G (p.Asn1489Ser)]

NM_014363.6(SACS):c.4466A>G (p.Asn1489Ser)

Gene:
SACS:sacsin molecular chaperone [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q12.12
Genomic location:
Preferred name:
NM_014363.6(SACS):c.4466A>G (p.Asn1489Ser)
HGVS:
  • NC_000013.11:g.23339410T>C
  • NG_012342.1:g.99293A>G
  • NM_001278055.2:c.4025A>G
  • NM_014363.6:c.4466A>GMANE SELECT
  • NP_001264984.1:p.Asn1342Ser
  • NP_055178.3:p.Asn1489Ser
  • NC_000013.10:g.23913549T>C
  • NM_014363.4:c.4466A>G
  • NM_014363.5:c.4466A>G
Protein change:
N1342S
Links:
dbSNP: rs147099630
NCBI 1000 Genomes Browser:
rs147099630
Molecular consequence:
  • NM_001278055.2:c.4025A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_014363.6:c.4466A>G - missense variant - [Sequence Ontology: SO:0001583]
Observations:
43

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001553855Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR)

See additional submitters

no assertion criteria provided
Uncertain significanceunknownclinical testing

SCV001906941GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Benign
(Oct 11, 2018)
germlineclinical testing

Citation Link,

SCV001929724Genome Diagnostics Laboratory, University Medical Center Utrecht - VKGL Data-share Consensus

See additional submitters

no assertion criteria provided
Likely benigngermlineclinical testing

SCV001970575Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center - VKGL Data-share Consensus

See additional submitters

no assertion criteria provided
Likely benigngermlineclinical testing

SCV004136811CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Likely benign
(May 1, 2024)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyes43not providednot providednot providednot providedclinical testing

Details of each submission

From Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR), SCV001553855.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The SACS p.Asn1342Ser variant was not identified in the literature nor was it identified in Cosmic, MutDB, and LOVD 3.0 databases. The variant was identified in dbSNP (ID: rs147099630) as "With Likely pathogenic allele". In ClinVar, there are five submissions with conflicting interpretations of pathogenicity: likely pathogenic (Lupski Lab, Baylor-Hopkins CMG,Baylor College of Medicine), benign (Invitae and EGL Genetic Diagnostics) and uncertain significance (Genetic Services Laboratory, University of Chicago). The associated conditions are: Spastic ataxia Charlevoix-Saguenay type, abnormality of brain morphology, and Spastic paraplegia. The variant was identified in control databases in 2472 of 278622 chromosomes (33 homozygous) at a frequency of 0.008872 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: Ashkenazi Jewish in 440 of 10136 chromosomes (freq: 0.04341), South Asian in 924 of 29334 chromosomes (freq: 0.0315), Other in 66 of 7086 chromosomes (freq: 0.009314), European (non-Finnish) in 880 of 127810 chromosomes (freq: 0.006885), while the variant was not observed in the Latino, European (Finnish), African, and East Asian populations. The variant was also identified in the following control databases: the 1000 Genomes Project, the NHLBI GO Exome Sequencing Project, the Exome Aggregation Consortium (August 8th 2016). The p.Asn1342 residue is conserved in mammals but not in more distantly related organisms and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, and BLOSUM) do not suggest a high likelihood of impact to the protein. MutationTaster predicts an impact to the protein. However, all this information is not predictive enough to rule out pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

From GeneDx, SCV001906941.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is associated with the following publications: (PMID: 26539891, 27980752)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Genome Diagnostics Laboratory, University Medical Center Utrecht - VKGL Data-share Consensus, SCV001929724.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center - VKGL Data-share Consensus, SCV001970575.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From CeGaT Center for Human Genetics Tuebingen, SCV004136811.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided43not providednot providedclinical testingnot provided

Description

SACS: BP4, BS2

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided43not providednot providednot provided

Last Updated: Jun 29, 2024